Lung cancer, Secondary cancers, Small cell lung cancer
Results
Phase 3
This trial looked at pembrolizumab and chemotherapy for people with small cell lung cancer that had spread to another part of the body. It was for people who were due to have treatment for the first time.
People could join the trial between 2017 and 2018. The team published the results in 2020 and 2023.
There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 15 May 2017
Recruitment end: 30 July 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Riyaz Shah
Merck Sharp & Dohme Ltd
Last reviewed: 13 Jul 2026
CRUK internal database number: 14851
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
